PD-1 Inhibition in Advanced Myeloproliferative Neoplasms

NCT03065400 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Chronic Phase Myelofibrosis
Primary Myelofibrosis
Post-essential Thrombocythemia Myelofibrosis
Polycythemia Vera

Interventions

DRUG: Pembrolizumab

Sponsor

John Mascarenhas

Collaborators

[object Object]
[object Object]